Last reviewed · How we verify

NCT06873022

EMG Biofeedback and NMES of Deltoid in Patients With rTSA

Recruiting now NA Last updated 12 March 2025
What this trial tests

NA trial testing neuromuscular electrical stimulation in Reverse Shoulder Replacement in 34 participants. Currently enrolling.

Timeline
15 March 2025
Primary endpoint
20 May 2025
20 May 2025

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment34
Start date15 March 2025
Primary completion20 May 2025
Estimated completion20 May 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 85, any sex, with Reverse Shoulder Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effect of NMES and surface electromyography (sEMG) biofeedback on the deltoid and associated scapular muscles in scapular kinematics and muscle activation in individual post rTSA

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of neuromuscular electrical stimulation

Trials testing the same drug.

Other recruiting trials for Reverse Shoulder Replacement

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06873022.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing